Sargent Bickham Lagudis’s Organon & Co OGN Stock Holding History

Sargent Bickham Lagudis’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$48.3K	Buy	1,732 +4	+0.2%	+$102	﹤0.01%	445
2022 Q3	$41K	Sell	1,728 -17	-1%	-$513	﹤0.01%	450
2022 Q2	$59K	Sell	1,745 -14	-0.8%	-$490	0.01%	391
2022 Q1	$61K	Sell	1,759 -138	-7%	-$4.72K	﹤0.01%	413
2021 Q4	$58K	Sell	1,897 -21	-1%	-$684	﹤0.01%	429
2021 Q3	$63K	Sell	1,918 -464	-19%	-$14.8K	0.01%	400
2021 Q2	$72K	Buy	+2,382	New	+$78.4K	0.01%	394

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sargent Bickham Lagudis's OGN Position: Q4 2022 in Review

Sargent Bickham Lagudis increased its Organon & Co (OGN) stake by 0.23% in Q4 2022, buying an estimated $102 and bringing the position to 1,732 shares worth $48.3K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

Sargent Bickham Lagudis first reported a position in OGN in Q2 2021 and has held it in 7 quarters since. The position peaked at $72K in Q2 2021. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

Sargent Bickham Lagudis held 1,732 shares of Organon & Co worth $48.3K as of Q4 2022.
Sargent Bickham Lagudis bought 4 Organon & Co shares in Q4 2022, an estimated $102.
Organon & Co made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #445 holding.
Sargent Bickham Lagudis first reported a position in Organon & Co in Q2 2021 and has held it in 7 quarters since.
Sargent Bickham Lagudis's Organon & Co position peaked at $72K in Q2 2021.
821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.